576 related articles for article (PubMed ID: 26048399)
1. Denser plasma clot formation and impaired fibrinolysis in paroxysmal and persistent atrial fibrillation while on sinus rhythm: association with thrombin generation, endothelial injury and platelet activation.
Drabik L; Wołkow P; Undas A
Thromb Res; 2015 Aug; 136(2):408-14. PubMed ID: 26048399
[TBL] [Abstract][Full Text] [Related]
2. Elevated NT-proBNP is associated with unfavorably altered plasma fibrin clot properties in atrial fibrillation.
Matusik PT; Matusik PS; Kornacewicz-Jach Z; Małecka B; Ząbek A; Undas A
Int J Cardiol; 2017 Sep; 243():244-250. PubMed ID: 28571619
[TBL] [Abstract][Full Text] [Related]
3. Increased plasma clot permeability and susceptibility to lysis are associated with heavy menstrual bleeding of unknown cause: a case-control study.
Szczepaniak P; Zabczyk M; Undas A
PLoS One; 2015; 10(4):e0125069. PubMed ID: 25909989
[TBL] [Abstract][Full Text] [Related]
4. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
Konieczynska M; Fil K; Bazanek M; Undas A
Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139
[TBL] [Abstract][Full Text] [Related]
5. Thromboembolic events are associated with prolonged clot lysis time in patients with permanent atrial fibrillation.
Ząbczyk M; Majewski J; Lelakowski J
Pol Arch Med Wewn; 2011 Nov; 121(11):400-7. PubMed ID: 22064373
[TBL] [Abstract][Full Text] [Related]
6. Altered plasma fibrin clot properties in essential thrombocythemia.
Małecki R; Gacka M; Kuliszkiewicz-Janus M; Jakobsche-Policht U; Kwiatkowski J; Adamiec R; Undas A
Platelets; 2016; 27(2):110-6. PubMed ID: 25989112
[TBL] [Abstract][Full Text] [Related]
7. Altered fibrin clot properties are associated with the progression of chronic kidney disease in atrial fibrillation.
Heleniak Z; Matusik PT; Undas A
Thromb Res; 2024 Apr; 236():14-21. PubMed ID: 38387299
[TBL] [Abstract][Full Text] [Related]
8. Prothrombotic State in Atrial Fibrillation Patients With One Additional Risk Factor of the CHA
Głowicki B; Matusik PT; Plens K; Undas A
Can J Cardiol; 2019 May; 35(5):634-643. PubMed ID: 30955928
[TBL] [Abstract][Full Text] [Related]
9. Clot Lysis Time Predicts Stroke During Anticoagulant Therapy in Patients with Atrial Fibrillation.
Drabik L; Konieczyńska M; Undas A
Can J Cardiol; 2020 Jan; 36(1):119-126. PubMed ID: 31740169
[TBL] [Abstract][Full Text] [Related]
10. Altered plasma fibrin clot properties and fibrinolysis in patients with multiple myeloma.
Undas A; Zubkiewicz-Usnarska L; Helbig G; Woszczyk D; Kozińska J; Dmoszyńska A; Podolak-Dawidziak M; Kuliczkowski K
Eur J Clin Invest; 2014 Jun; 44(6):557-66. PubMed ID: 24738991
[TBL] [Abstract][Full Text] [Related]
11. Altered fibrin clot properties in patients with chronic heart failure and sinus rhythm: a novel prothrombotic mechanism.
Palka I; Nessler J; Nessler B; Piwowarska W; Tracz W; Undas A
Heart; 2010 Jul; 96(14):1114-8. PubMed ID: 20610458
[TBL] [Abstract][Full Text] [Related]
12. Unfavorably Altered Fibrin Clot Properties in Patients with Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Association with Thrombin Generation and Eosinophilia.
Mastalerz L; Celińska-Lӧwenhoff M; Krawiec P; Batko B; Tłustochowicz W; Undas A
PLoS One; 2015; 10(11):e0142167. PubMed ID: 26540111
[TBL] [Abstract][Full Text] [Related]
13. Altered plasma fibrin clot properties in patients with digestive tract cancers: links with the increased thrombin generation.
Gronostaj K; Richter P; Nowak W; Undas A
Thromb Res; 2013 Mar; 131(3):262-7. PubMed ID: 23273404
[TBL] [Abstract][Full Text] [Related]
14. Elevated 8-isoprostane concentration is associated with thromboembolic events in patients with atrial fibrillation.
Mołek P; Chmiel J; Ząbczyk M; Malinowski KP; Natorska J; Undas A
Int J Cardiol; 2022 Oct; 365():1-7. PubMed ID: 35868355
[TBL] [Abstract][Full Text] [Related]
15. Assays of fibrin network properties altered by VKAs in atrial fibrillation - importance of using an appropriate coagulation trigger.
Ząbczyk M; Blombäck M; Majewski J; Karkowski G; Wallen HN; Undas A; He S
Thromb Haemost; 2015 Apr; 113(4):851-61. PubMed ID: 25518887
[TBL] [Abstract][Full Text] [Related]
16. Fibrin clot characteristics in acute ischaemic stroke patients treated with thrombolysis: the impact on clinical outcome.
Bembenek JP; Niewada M; Siudut J; Plens K; Członkowska A; Undas A
Thromb Haemost; 2017 Jun; 117(7):1440-1447. PubMed ID: 28382369
[TBL] [Abstract][Full Text] [Related]
17. Reduced plasma fibrin clot permeability and susceptibility to fibrinolysis are associated with increased intima-media thickness in patients with primary antiphospholipid syndrome.
Asztabski M; Wypasek E; Ząbczyk M; Undas A
Thromb Res; 2014 Nov; 134(5):945-51. PubMed ID: 25194881
[TBL] [Abstract][Full Text] [Related]
18. Induction therapy alters plasma fibrin clot properties in multiple myeloma patients: association with thromboembolic complications.
Undas A; Zubkiewicz-Usnarska L; Helbig G; Woszczyk D; Kozińska J; Dmoszyńska A; Dębski J; Podolak-Dawidziak M; Kuliczkowski K
Blood Coagul Fibrinolysis; 2015 Sep; 26(6):621-7. PubMed ID: 26083985
[TBL] [Abstract][Full Text] [Related]
19. Prothrombotic alterations in plasma fibrin clot properties in thyroid disorders and their post-treatment modifications.
Mazur P; Sokołowski G; Hubalewska-Dydejczyk A; Płaczkiewicz-Jankowska E; Undas A
Thromb Res; 2014 Aug; 134(2):510-7. PubMed ID: 24962680
[TBL] [Abstract][Full Text] [Related]
20. Plasma fibrin clot properties in the G20210A prothrombin mutation carriers following venous thromboembolism: the effect of rivaroxaban.
Janion-Sadowska A; Natorska J; Siudut J; Ząbczyk M; Stanisz A; Undas A
Thromb Haemost; 2017 Aug; 117(9):1739-1749. PubMed ID: 28771277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
